BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24229687)

  • 1. Prognostic value of lymph node ratio in hypopharyngeal squamous cell carcinoma after chemoradiotherapy.
    Yu Y; Wang XL; Xu ZG; Fan CC; Li Q
    Chin Med J (Engl); 2013 Nov; 126(21):4139-44. PubMed ID: 24229687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma.
    Sano D; Yabuki K; Takahashi H; Arai Y; Chiba Y; Tanabe T; Nishimura G; Oridate N
    Auris Nasus Larynx; 2018 Aug; 45(4):846-853. PubMed ID: 29203318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of the number of lymph nodes retrieved after selective neck dissection in hypopharyngeal squamous carcinoma].
    Yu Y; Wang XL; Xu ZG; Li Q
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Feb; 48(2):148-53. PubMed ID: 23710866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lymph node ratio in laryngeal and hypopharyngeal squamous cell carcinoma: a systematic review and meta-analysis.
    Abdeyrim A; He S; Zhang Y; Mamtali G; Asla A; Yusup M; Liu J
    J Otolaryngol Head Neck Surg; 2020 May; 49(1):31. PubMed ID: 32471483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neck dissection after chemoradiotherapy for oropharyngeal and hypopharyngeal cancer: the correlation between cervical lymph node metastasis and prognosis.
    Hanai N; Kawakita D; Ozawa T; Hirakawa H; Kodaira T; Hasegawa Y
    Int J Clin Oncol; 2014 Feb; 19(1):30-7. PubMed ID: 23340917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
    Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
    Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Survival Nomogram Containing Lymph Node Ratio for Hypopharyngeal Carcinoma Patients After Neck Dissection.
    Li F; Huang Q; Hsueh C; Huang H; Zhu Y; Gong H; Tao L; Zhou L; Zhang M
    Otolaryngol Head Neck Surg; 2023 May; 168(5):1097-1106. PubMed ID: 36939525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Lymph Node Ratio in Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Tseros EA; Gebski V; Morgan GJ; Veness MJ
    Ann Surg Oncol; 2016 May; 23(5):1693-8. PubMed ID: 26786095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical evaluation of lymph node ratio in head and neck cancer.
    de Ridder M; Marres CC; Smeele LE; van den Brekel MW; Hauptmann M; Balm AJ; van Velthuysen ML
    Virchows Arch; 2016 Dec; 469(6):635-641. PubMed ID: 27639568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of lymph node ratio for patients with mandibular infiltration of oral squamous cell carcinoma.
    Safi AF; Kauke M; Grandoch A; Nickenig HJ; Zöller J; Kreppel M
    J Craniomaxillofac Surg; 2018 Jun; 46(6):1007-1012. PubMed ID: 29709331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necessity of level IV dissection in cN0 hypopharyngeal carcinoma.
    Shin YS; Kim SH; Koh YW; Hong HJ; Seol JH; Choi EC
    Acta Otolaryngol; 2011 Jun; 131(6):665-9. PubMed ID: 21395474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of the clinical efficacy of definitive chemoradiotherapy for patients with hypopharyngeal cancer.
    Takehana K; Kodaira T; Tachibana H; Kimura K; Shimizu A; Makita C; Tomita N; Nishikawa D; Suzuki H; Hirakawa H; Hanai N; Hasegawa Y
    Jpn J Clin Oncol; 2016 Apr; 46(4):344-9. PubMed ID: 26826721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis.
    Wang YL; Feng SH; Zhu J; Zhu GP; Li DS; Wang Y; Zhu YX; Sun GH; Ji QH
    PLoS One; 2013; 8(2):e56613. PubMed ID: 23431384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between lymph node ratio and survival outcomes in patients with oral squamous cell carcinoma.
    Haraguchi K; Habu M; Takahashi O; Tominaga K; Yoshioka I; Sasaguri M
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101816. PubMed ID: 38458548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Metastatic Lymph node ratio be used as an independent prognostic factor in Carcinoma tongue?
    Bharath VM; Balagopal PG; Nebu AG; Jayasudha AV; Iqbal Ahmed M; Sebastian P
    Gulf J Oncolog; 2018 Sep; 1(28):6-10. PubMed ID: 30344127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
    Wang J; Liu Y; Shayan G; Ma Y; Yi J
    Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node ratio as a valuable additional predictor of outcome in selected patients with oral cavity cancer.
    Künzel J; Mantsopoulos K; Psychogios G; Grundtner P; Koch M; Iro H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):677-84. PubMed ID: 24842444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative staging of the neck dissection using extracapsular spread and lymph node ratio as prognostic factors in HPV-negative head and neck squamous cell carcinoma patients.
    Majercakova K; Valero C; López M; García J; Farré N; Quer M; León X
    Oral Oncol; 2018 Feb; 77():37-42. PubMed ID: 29362124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.